JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael T. Kronon
Bradley S. Allen
Ari Halldorsson
Michel Ilbawi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kronon, M. T.
Right arrow Articles by Ilbawi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kronon, M. T.
Right arrow Articles by Ilbawi, M.
Related Collections
Right arrow Congenital - acyanotic
Right arrow Congenital - cyanotic
Right arrow Myocardial protection

J Thorac Cardiovasc Surg 2002;123:119-129
© 2002 The American Association for Thoracic Surgery


Surgery for Congential Heart Disease

Delivery of a nonpotassium modified maintenance solution to enhance myocardial protection in stressed neonatal hearts: A new approach

Michael T. Kronon, MD*, Bradley S. Allen, MD, Ari Halldorsson, MD, Shaikh Rahman, PhD, Mary Jane Barth, MD, Michel Ilbawi, MD

From The Division of Cardiovascular Surgery, The Heart Institute for Children, Hope Children's Hospital, Oak Lawn, Ill, and The Division of Cardiothoracic Surgery, The University of Illinois of Chicago, Chicago, Ill.

*Supported in part by the Pillsbury Fellowship.

Received for publication Sept 13, 2000. Revisions requested Feb 2, 2001; revisions received June 6, 2001. Accepted for publication July 27, 2001. Address for reprints: Bradley S. Allen, MD, The Heart Institute for Children, Hope Children's Hospital, 4440 W 95th St, Oak Lawn, IL 60453.

Abstract

Objectives: This study was undertaken to compare conventional cardioplegic strategies with a new approach that uses a modified nonpotassium maintenance solution between cardioplegia doses in stressed neonatal hearts.
Methods: Thirty-five neonatal piglets underwent 60 minutes of ventilator hypoxia (inspired oxygen fraction 8%-10%) followed by 20 minutes of ischemia on cardiopulmonary bypass. In 10 animals bypass was discontinued without further ischemia (stress control group). The other 25 received a warm blood cardioplegic induction and were separated into 5 groups. In 5 animals cardiopulmonary bypass was discontinued without further ischemia (cardioplegia control group); the remaining 20 underwent an additional 70 minutes of cold blood cardioplegic arrest. Five received only intermittent cardioplegia every 20 minutes, whereas 15 also received cold blood maintenance infusions between cardioplegic doses (integrated strategy). In 5 of these animals the blood was unmodified, whereas in 10 a modified nonpotassium "cardioplegia-like" solution was delivered either antegradely (n = 5) or retrogradely (n = 5). Myocardial function was assessed by pressure-volume loops (expressed as percentage of control); vascular function was assessed by coronary vascular resistance.
Results: All piglets that underwent hypoxic ischemic stress alone (controls) died. Warm induction alone (cardioplegic controls) partially repaired the stress injury. Intermittent cardioplegia preserved the depressed systolic function (end-systolic elastance 40% vs 39%), increased diastolic stiffness (255% vs 239%), reduced adenosine triphosphate (10.6 vs 12.2 µg/g tissue), and elevated coronary vascular resistance at levels identical to warm induction alone; infusing unmodified blood between cardioplegia doses (standard integrated) improved results slightly. In contrast, infusion of a cold modified solution (antegrade or retrograde) between cardioplegia doses (modified integrated) completely restored systolic function (end-systolic elastance 100% and 97%, P < .001 vs intermittent and standard integrated), only minimally increased diastolic stiffness (159% and 156%, P < .001 vs intermittent and standard integrated), restored adenosine triphosphate (18.8 and 16.6 µg/g, P < .001 vs intermittent and standard integrated), and normalized coronary vascular resistance (P < .001 vs intermittent and standard integrated). This strategy was used in 72 consecutive hypoxic patients (21 arterial switch operations, retrograde; 51 Fontan procedures, antegrade) with a 2.8% mortality.
Conclusions: Infusion of a cold modified solution between cardioplegic doses (modified integrated protection) significantly improved myocardial protection in the stressed neonatal heart, was effective delivered either antegradely or retrogradely, and was used successfully for hypoxic (stressed) pediatric patients.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. J. Barth, B. S. Allen, M. Gulecyuz, P. Chiemmongkoltip, B. Cuneo, and M. N. Ilbawi
Experience with an alternative technique for the management of anomalous left coronary artery from the pulmonary artery
Ann. Thorac. Surg., November 1, 2003; 76(5): 1429 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. S. Allen, C. El-Zein, B. Cuneo, J. P. Cava, M. J. Barth, and M. N. Ilbawi
Pericardial tissue valves and gore-tex conduits as an alternative for right ventricular outflow tract replacement in children
Ann. Thorac. Surg., September 1, 2002; 74(3): 771 - 777.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
B. S Allen
The role of leukodepletion in limiting ischemia/reperfusion damage in the heart, lung and lower extremity
Perfusion, March 1, 2002; 17(2_suppl): 11 - 22.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.